Evidence map›Paper›PMID 33800346›Full record

ArticleCancers2021

Patterns of Sequelae in Women with a History of Localized Breast Cancer: Results from the French VICAN Survey.

Lidia Delrieu, Liacine Bouaoun, Douae El Fatouhi, Elise Dumas, Anne-Deborah Bouhnik, Hugo Noelle, Emmanuelle Jacquet, Anne-Sophie Hamy, Florence Coussy, Fabien Reyal and 7 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Lidia DelrieuDepartment Prevention, Cancer, Environment, Léon Bérard Cancer Center, 69008 Lyon, France.
Liacine BouaounInternational Agency for Research on Cancer, 69372 Lyon, France.
Douae El FatouhiCenter of Research in Epidemiology and Population Health, UMR 1018 Inserm, Institut Gustave Roussy, Paris-Sud Paris-Saclay University, 94807 Villejuif, France.
Elise DumasResidual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris University, 75005 Paris, France.ORCID 0000-0002-7877-719X
Anne-Deborah BouhnikINSERM, IRD, SESSTIM, Economics & Social Sciences Applied to Health & Analysis of Medical Information, Aix Marseille University, 13007 Marseille, France.ORCID 0000-0002-5418-4592
Hugo NoelleDepartment Prevention, Cancer, Environment, Léon Bérard Cancer Center, 69008 Lyon, France.
Emmanuelle JacquetOncology and Blood Diseases Department, University Hospital Center, Joseph Fourier University, CEDEX 9, 38043 Grenoble, France.ORCID 0000-0001-5445-9720
Anne-Sophie HamyResidual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris University, 75005 Paris, France.ORCID 0000-0003-4430-3022
Florence CoussyResidual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris University, 75005 Paris, France.
Fabien ReyalResidual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris University, 75005 Paris, France.
Pierre-Etienne HeudelDepartment of Medical Oncology, Léon Bérard Cancer Center, 69008 Lyon, France.ORCID 0000-0002-2155-549X
Marc-Karim BendianeINSERM, IRD, SESSTIM, Economics & Social Sciences Applied to Health & Analysis of Medical Information, Aix Marseille University, 13007 Marseille, France.
Baptiste FournierDepartment Prevention, Cancer, Environment, Léon Bérard Cancer Center, 69008 Lyon, France.
Mauricette MichalletDepartment of Medical Oncology, Léon Bérard Cancer Center, 69008 Lyon, France.
Béatrice FerversDepartment Prevention, Cancer, Environment, Léon Bérard Cancer Center, 69008 Lyon, France.
Guy FagherazziCenter of Research in Epidemiology and Population Health, UMR 1018 Inserm, Institut Gustave Roussy, Paris-Sud Paris-Saclay University, 94807 Villejuif, France.
Olivia PérolDepartment Prevention, Cancer, Environment, Léon Bérard Cancer Center, 69008 Lyon, France.
Inserm · FRCentre de Recherche en Cancérologie de Lyon · FRCentre international de recherche sur le cancer · FRUniversité Joseph Fourier · FR

Funding

World Health Organization 001
6 · The paper itself

Abstract

Breast cancer (BC) remains complex for women both physically and psychologically. The objectives of this study were to (1) assess the evolution of the main sequelae and treatment two and five years after diagnosis in women with early-stage breast cancer, (2) explore patterns of sequelae associated with given sociodemographic, clinical, and lifestyle factors. The current analysis was based on 654 localized BC patients enrolled in the French nationwide longitudinal survey "vie après cancer" VICAN (January-June 2010). Information about study participants was collected at enrollment, two and five years after diagnosis. Changes over time of the main sequelae were analyzed and latent class analysis was performed to identify patterns of sequelae related to BC five years after diagnosis. The mean age (±SD) of study participants at inclusion was 49.7 (±10.5) years old. Six main classes of sequelae were identified two years and five years post-diagnosis (functional, pain, esthetic, fatigue, psychological, and gynecological). A significant decrease was observed for fatigue (

Indexed as

breast cancerpreventionsequelaeVICAN

Identifiers

PMID33800346
PMCPMC7962808
OpenAlexW3133810097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.